598 related articles for article (PubMed ID: 32728795)
1. The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics.
Kent SA; Spires-Jones TL; Durrant CS
Acta Neuropathol; 2020 Oct; 140(4):417-447. PubMed ID: 32728795
[TBL] [Abstract][Full Text] [Related]
2. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
3. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
Winton MJ; Lee EB; Sun E; Wong MM; Leight S; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2011 May; 31(21):7691-9. PubMed ID: 21613482
[TBL] [Abstract][Full Text] [Related]
4. GSK-3 and Tau: A Key Duet in Alzheimer's Disease.
Sayas CL; Ávila J
Cells; 2021 Mar; 10(4):. PubMed ID: 33804962
[TBL] [Abstract][Full Text] [Related]
5. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
6. Role of tau protein in Alzheimer's disease: The prime pathological player.
Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
[TBL] [Abstract][Full Text] [Related]
7. Targeting Abeta and tau in Alzheimer's disease, an early interim report.
Golde TE; Petrucelli L; Lewis J
Exp Neurol; 2010 Jun; 223(2):252-66. PubMed ID: 19716367
[TBL] [Abstract][Full Text] [Related]
8. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
9. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
10. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.
Kar S; Slowikowski SP; Westaway D; Mount HT
J Psychiatry Neurosci; 2004 Nov; 29(6):427-41. PubMed ID: 15644984
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
12. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
13. The role of tau kinases in Alzheimer's disease.
Dolan PJ; Johnson GV
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):595-603. PubMed ID: 20812151
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
15. Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain.
Winer JR; Mander BA; Helfrich RF; Maass A; Harrison TM; Baker SL; Knight RT; Jagust WJ; Walker MP
J Neurosci; 2019 Aug; 39(32):6315-6324. PubMed ID: 31209175
[TBL] [Abstract][Full Text] [Related]
16. Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.
Gulisano W; Maugeri D; Baltrons MA; Fà M; Amato A; Palmeri A; D'Adamio L; Grassi C; Devanand DP; Honig LS; Puzzo D; Arancio O
J Alzheimers Dis; 2018; 64(s1):S611-S631. PubMed ID: 29865055
[TBL] [Abstract][Full Text] [Related]
17. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
[TBL] [Abstract][Full Text] [Related]
18. Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in Mice.
Ghosal K; Fan Q; Dawson HN; Pimplikar SW
PLoS One; 2016; 11(7):e0159435. PubMed ID: 27459671
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-β-independent regulators of tau pathology in Alzheimer disease.
van der Kant R; Goldstein LSB; Ossenkoppele R
Nat Rev Neurosci; 2020 Jan; 21(1):21-35. PubMed ID: 31780819
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
